Stock listing

Replicel Life Sciences Inc.

Selected listing: REPCF · OTC · USD · US

Replicel Life Sciences Inc. (OTC:REPCF), Health Technology. Latest release Aug 5, 2020: BCSC Revocation of Cease Trade Order.

REPCF:OTCUSDUSUpdated September 25, 2026
Replicel Life Sciences Inc. logo
Ticker
OTC:REPCF
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD

About Replicel Life Sciences Inc.

Replicel Life Sciences Inc. is a public company traded under the ticker REPCF in the American market. The company focuses on developing innovative regenerative medicine therapies aimed at treating conditions such as hair loss and tendon injuries. Replicel is dedicated to advancing its research and development efforts to bring new treatment options to patients.

Latest news from Replicel Life Sciences Inc.

BCSC Revocation of Cease Trade Order

August 4, 2020

BCSC Cease Trade Order

June 16, 2020

RepliCel Announces its Incoming Board of Directors

December 23, 2019

RepliCel Provides 2019 Year-End Update

November 26, 2019

Clinical Data Published from RepliCel's Skin Rejuvenation Study

September 24, 2019

All Replicel Life Sciences Inc. news →

Research Replicel Life Sciences Inc.

Replicel Life Sciences Inc. company profile

View the public company page for Replicel Life Sciences Inc. on 6ix.

Replicel Life Sciences Inc. news

Read company news and market updates connected to Replicel Life Sciences Inc..

Replicel Life Sciences Inc. investor events

Find investor webinars, events, and replay context for Replicel Life Sciences Inc..